Artwork

optimalhealthweekly द्वारा प्रदान की गई सामग्री. एपिसोड, ग्राफिक्स और पॉडकास्ट विवरण सहित सभी पॉडकास्ट सामग्री optimalhealthweekly या उनके पॉडकास्ट प्लेटफ़ॉर्म पार्टनर द्वारा सीधे अपलोड और प्रदान की जाती है। यदि आपको लगता है कि कोई आपकी अनुमति के बिना आपके कॉपीराइट किए गए कार्य का उपयोग कर रहा है, तो आप यहां बताई गई प्रक्रिया का पालन कर सकते हैं https://hi.player.fm/legal
Player FM - पॉडकास्ट ऐप
Player FM ऐप के साथ ऑफ़लाइन जाएं!

The Viral Social Media 'Ice Bucket Challenge' help fund a new ALS treatment, but experts have varying opinions about its approval

21:20
 
साझा करें
 

Manage episode 345746529 series 3320312
optimalhealthweekly द्वारा प्रदान की गई सामग्री. एपिसोड, ग्राफिक्स और पॉडकास्ट विवरण सहित सभी पॉडकास्ट सामग्री optimalhealthweekly या उनके पॉडकास्ट प्लेटफ़ॉर्म पार्टनर द्वारा सीधे अपलोड और प्रदान की जाती है। यदि आपको लगता है कि कोई आपकी अनुमति के बिना आपके कॉपीराइट किए गए कार्य का उपयोग कर रहा है, तो आप यहां बताई गई प्रक्रिया का पालन कर सकते हैं https://hi.player.fm/legal

In this episode of Optimal Health Weekly we discuss the Ice Bucket Challenge funding research for ALS. ALS or or Lou Gehrig’s disease is a nervous system disease that impacts nerve cells that control our voluntary muscle movement. For most patients, symptoms do get worse over time, resulting in respiratory failure.

Remember the “Ice Bucket Challenge” in 2015? People around the world were dropping buckets full of ice water on their heads and donating money to support the good cause. The IceBucket challenge was started by people with amyotrophic lateral sclerosis disease to help raise awareness for the condition.

The viral social media trend also raised $215 million dollars in donations. The ALS association invested some of the donation money into developing and trialling a new therapy for ALS. This year, the Food and Drug Administration approved stem cell therapy clinical trials to treat ALS.

Stem cells along with Biologic ALS treatments, can add nearly eighteen months onto patients’ lives. Risk for the first hospitalization was measured at a 54% decrease in those receiving the therapy. These were very significant markers of disease progression. While people living with ALS are excited about the approval, some experts believe it was green lit too soon and without scrutiny.

Links mentioned in show:

Previous shows:

1- Weekly Wellness Talk Ep 1

2 - Risks and Benefits of Intermittent Fasting

3- Confronting Alzheimer's

4 - Prevent and treat heart disease

5 - Chronic Liver Disease

6 - Lung Injuries Associated with Vaping

7 - Crohn's and Ulcerative Colitis

8 - Kidney Failure & IgA Nephropathy

9 - Brain Injuries

10 - Stroke

11 - Spinal Injury

12 - Lyme Disease

13 - Autoimmune Disease

14 - Diabetes

15 - Parkinsons

  continue reading

20 एपिसोडस

Artwork
iconसाझा करें
 
Manage episode 345746529 series 3320312
optimalhealthweekly द्वारा प्रदान की गई सामग्री. एपिसोड, ग्राफिक्स और पॉडकास्ट विवरण सहित सभी पॉडकास्ट सामग्री optimalhealthweekly या उनके पॉडकास्ट प्लेटफ़ॉर्म पार्टनर द्वारा सीधे अपलोड और प्रदान की जाती है। यदि आपको लगता है कि कोई आपकी अनुमति के बिना आपके कॉपीराइट किए गए कार्य का उपयोग कर रहा है, तो आप यहां बताई गई प्रक्रिया का पालन कर सकते हैं https://hi.player.fm/legal

In this episode of Optimal Health Weekly we discuss the Ice Bucket Challenge funding research for ALS. ALS or or Lou Gehrig’s disease is a nervous system disease that impacts nerve cells that control our voluntary muscle movement. For most patients, symptoms do get worse over time, resulting in respiratory failure.

Remember the “Ice Bucket Challenge” in 2015? People around the world were dropping buckets full of ice water on their heads and donating money to support the good cause. The IceBucket challenge was started by people with amyotrophic lateral sclerosis disease to help raise awareness for the condition.

The viral social media trend also raised $215 million dollars in donations. The ALS association invested some of the donation money into developing and trialling a new therapy for ALS. This year, the Food and Drug Administration approved stem cell therapy clinical trials to treat ALS.

Stem cells along with Biologic ALS treatments, can add nearly eighteen months onto patients’ lives. Risk for the first hospitalization was measured at a 54% decrease in those receiving the therapy. These were very significant markers of disease progression. While people living with ALS are excited about the approval, some experts believe it was green lit too soon and without scrutiny.

Links mentioned in show:

Previous shows:

1- Weekly Wellness Talk Ep 1

2 - Risks and Benefits of Intermittent Fasting

3- Confronting Alzheimer's

4 - Prevent and treat heart disease

5 - Chronic Liver Disease

6 - Lung Injuries Associated with Vaping

7 - Crohn's and Ulcerative Colitis

8 - Kidney Failure & IgA Nephropathy

9 - Brain Injuries

10 - Stroke

11 - Spinal Injury

12 - Lyme Disease

13 - Autoimmune Disease

14 - Diabetes

15 - Parkinsons

  continue reading

20 एपिसोडस

همه قسمت ها

×
 
Loading …

प्लेयर एफएम में आपका स्वागत है!

प्लेयर एफएम वेब को स्कैन कर रहा है उच्च गुणवत्ता वाले पॉडकास्ट आप के आनंद लेंने के लिए अभी। यह सबसे अच्छा पॉडकास्ट एप्प है और यह Android, iPhone और वेब पर काम करता है। उपकरणों में सदस्यता को सिंक करने के लिए साइनअप करें।

 

त्वरित संदर्भ मार्गदर्शिका